A detailed history of Public Employees Retirement Association Of Colorado transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Public Employees Retirement Association Of Colorado holds 279,883 shares of BMY stock, worth $14.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
279,883
Previous 287,431 2.63%
Holding current value
$14.9 Million
Previous $15.6 Million 25.43%
% of portfolio
0.05%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $303,807 - $399,968
-7,548 Reduced 2.63%
279,883 $11.6 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $770,366 - $873,446
-16,056 Reduced 5.29%
287,431 $15.6 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $971,587 - $1.16 Million
-20,041 Reduced 6.19%
303,487 $15.6 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $18.1 Million - $20.3 Million
313,337 Added 3074.64%
323,528 $18.8 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $18.9 Million - $21.1 Million
-326,669 Reduced 96.97%
10,191 $269,000
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $727,249 - $807,497
-11,415 Reduced 3.28%
336,860 $21.5 Million
Q1 2023

May 08, 2023

SELL
$65.71 - $74.53 $865,794 - $982,007
-13,176 Reduced 3.65%
348,275 $24.1 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $44,032 - $52,140
-643 Reduced 0.18%
361,451 $26 Million
Q3 2022

Nov 15, 2022

BUY
$0.13 - $76.84 $1,371 - $810,431
10,547 Added 3.0%
362,094 $25.7 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $844,134 - $929,687
-11,624 Reduced 3.2%
351,547 $27.1 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $421,875 - $505,866
-6,862 Reduced 1.85%
363,171 $26.5 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $1.01 Million - $1.17 Million
-18,761 Reduced 4.83%
370,033 $23.1 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $57,927 - $67,854
-979 Reduced 0.25%
388,794 $23 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $803,901 - $875,448
-12,985 Reduced 3.22%
389,773 $26 Million
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $135,710 - $152,634
-2,287 Reduced 0.56%
402,758 $25.4 Million
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $1.05 Million - $1.19 Million
-18,255 Reduced 4.31%
405,045 $25.1 Million
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $37,501 - $41,556
-653 Reduced 0.15%
423,300 $25.5 Million
Q2 2020

Aug 05, 2020

SELL
$54.82 - $64.09 $1.13 Million - $1.32 Million
-20,658 Reduced 4.65%
423,953 $24.9 Million
Q1 2020

May 01, 2020

BUY
$46.4 - $67.43 $860,070 - $1.25 Million
18,536 Added 4.35%
444,611 $24.8 Million
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $6.3 Million - $8.22 Million
128,048 Added 42.97%
426,075 $27.4 Million
Q3 2019

Nov 05, 2019

SELL
$42.77 - $50.71 $26,346 - $31,237
-616 Reduced 0.21%
298,027 $15.1 Million
Q2 2019

Jul 31, 2019

SELL
$44.62 - $49.34 $50.6 Million - $56 Million
-1,134,482 Reduced 79.16%
298,643 $13.5 Million
Q1 2019

Apr 30, 2019

BUY
$45.12 - $53.8 $628,341 - $749,218
13,926 Added 0.98%
1,433,125 $68.4 Million
Q4 2018

Feb 08, 2019

SELL
$48.76 - $63.23 $33,595 - $43,565
-689 Reduced 0.05%
1,419,199 $73.8 Million
Q3 2018

Oct 29, 2018

SELL
$55.19 - $62.25 $16,998 - $19,173
-308 Reduced 0.02%
1,419,888 $88.1 Million
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $1.27 Million - $1.59 Million
-25,180 Reduced 1.74%
1,420,196 $78.6 Million
Q1 2018

May 01, 2018

SELL
$59.92 - $68.98 $2.95 Million - $3.39 Million
-49,208 Reduced 3.29%
1,445,376 $91.4 Million
Q4 2017

Feb 02, 2018

BUY
$59.94 - $65.35 $4.82 Million - $5.26 Million
80,428 Added 5.69%
1,494,584 $91.6 Million
Q3 2017

Oct 30, 2017

BUY
$55.23 - $63.74 $78.1 Million - $90.1 Million
1,414,156
1,414,156 $90.1 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Public Employees Retirement Association Of Colorado Portfolio

Follow Public Employees Retirement Association Of Colorado and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.